Pearson plc
NYSE:PSOPublishing
-$0.11 today
- Market cap
- $10.27B
- Beta
- -0.04
- P/E (TTM)
- 21.4
- EPS (TTM)
- $0.53
- Dividend yield
- 2.24%
Volume 0.58M
Average 1.04M
PSO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Pearson plcNYSE: PSO
Research & Development · Q4 FY2025 · quarter ended Dec 2025
Research & development turns positive
Q4 FY2025 research & development was £0, compared with -£144M a year earlier.
Context
- Research & development amounted to 0.0% of revenue in FY2025, down 8.2 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
GBP · from the income statement
- Latest · FY2025
- 0 GBP
- Year-over-year change
- -100.0%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 291M | +2.5% |
| FY2023 | 2023-12-31 | 284M | -6.3% |
| FY2022 | 2022-12-31 | 303M | +8.6% |
| FY2021 | 2021-12-31 | 279M | — |
Research & Development vs competitors
How PSO compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.0% is the lowest of 4, against a peer median of +11.2%.
- Research & development amounts to 0.0% of revenue for PSO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
MHMcGraw Hill, Inc. | LTM Jun 2026 | $270.64M USD | +35.9% | -0.2% | 12.8% |
| LTM Apr 2026 | $54.58M USD | -8.0% | -7.3% | 11.3% | |
| LTM Mar 2026 | $52.17M USD | +11.2% | +26.5% | 20.8% | |
| FY2025 | £0 GBP | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jul 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Feb 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding PSO) | — | +11.2% | -0.2% | 0.0% | |
Competitors are the stored peer set for PSO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.43B | 3.84B | 3.67B | 3.55B | 3.58B |
| Cost of Revenue | 1.75B | 2.05B | 1.84B | 1.74B | 1.72B |
| Gross Profit | 1.68B | 1.8B | 1.84B | 1.81B | 1.86B |
| Gross Margin | 49.0% | 46.7% | 49.9% | 51.0% | 52.0% |
| Research & Development | 279M | 303M | 284M | 291M | 0 |
| Selling, General & Admin | 1.39B | 1.45B | 1.36B | 1.31B | 1.3B |
| Operating Expenses | 1.5B | 1.52B | 1.34B | 1.27B | 1.26B |
| Depreciation & Amortization | 518M | 551M | 543M | 526M | 571M |
| EBITDA | 751M | 930M | 1.1B | 1.12B | 1.1B |
| EBITDA Margin | 21.9% | 24.2% | 29.9% | 31.4% | 30.8% |
| Operating Income | 183M | 271M | 498M | 541M | 618.15M |
| Operating Margin | 5.3% | 7.1% | 13.6% | 15.2% | 17.3% |
| Interest Income | 15M | 67M | 50M | 55M | 16.63M |
| Interest Expense | 68M | 69M | 61M | 79M | 69.44M |
| Other Income / Expenses | (6M) | 51M | (5M) | (31M) | (171.16M) |
| Income Before Tax | 177M | 322M | 493M | 510M | 446.99M |
| Pre-Tax Margin | 5.2% | 8.4% | 13.4% | 14.4% | 12.5% |
| Income Tax Expense | (1M) | 79M | 113M | 75M | 118.35M |
| Net Income | 177M | 242M | 378M | 434M | 327.66M |
| Net Margin | 5.2% | 6.3% | 10.3% | 12.2% | 9.2% |
| EPS (Basic) | 0.23 | 0.33 | 0.53 | 0.63 | 0.50 |
| EPS (Diluted) | 0.23 | 0.33 | 0.53 | 0.63 | 0.50 |
| Weighted Avg Shares | 754.1M | 738.1M | 717.27M | 688.6M | 651.3M |
| Weighted Avg Shares (Diluted) | 759.1M | 742M | 717.3M | 684M | 660.3M |
Pearson plc
NYSE:PSO
Intrinsic Alpha fair value
Locked
Current Price
$17.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.